Kodiak Sciences (KOD) Total Liabilities (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Total Liabilities came in at $193.9 million in Q1 2026, up 2.56% YoY from $189.1 million in Q1 2025, and little changed on a QoQ basis from $194.1 million in Q4 2025.
Kodiak Sciences (KOD) Total Liabilities (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Total Liabilities data on file, last reported at $193.9 million in Q1 2026.
- Quarterly Total Liabilities rose 2.56% year-over-year to $193.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.9 million (up 2.56% YoY) and the FY2025 annual result came in at $194.1 million, up 4.78% from the prior year.
- Total Liabilities was little changed at $193.9 million in Q1 2026, from $194.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $252.9 million in Q1 2022 to a low of $185.3 million in Q4 2024.
- A 5-year average of $214.6 million and a median of $194.4 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities advanced 19.83% — and 2024, when it dropped 25.52%.
- Tracing KOD's Total Liabilities over 5 years: stood at $230.5 million in 2022, then decreased by 7.32% to $213.6 million in 2023, then slipped by 13.25% to $185.3 million in 2024, then advanced by 4.78% to $194.1 million in 2025, then fell by 0.13% to $193.9 million in 2026.
- The last three Total Liabilities figures came in at $193.9 million (Q1 2026), $194.1 million (Q4 2025), and $194.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | 195.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 195.72 Mn |
| Mar 31, 2026 | 193.91 Mn |
| Dec 31, 2025 | 194.15 Mn |
| Sep 30, 2025 | 194.38 Mn |
| Jun 30, 2025 | 186.44 Mn |
| Mar 31, 2025 | 189.07 Mn |
| Dec 31, 2024 | 185.29 Mn |
| Sep 30, 2024 | 187.30 Mn |
| Jun 30, 2024 | 187.07 Mn |
| Mar 31, 2024 | 193.57 Mn |
| Dec 31, 2023 | 213.59 Mn |
| Sep 30, 2023 | 245.24 Mn |
| Jun 30, 2023 | 251.18 Mn |
| Mar 31, 2023 | 247.75 Mn |
| Dec 31, 2022 | 230.46 Mn |
| Sep 30, 2022 | 244.46 Mn |
| Jun 30, 2022 | 250.97 Mn |
| Mar 31, 2022 | 252.90 Mn |
| Dec 31, 2021 | 240.90 Mn |
| Sep 30, 2021 | 231.89 Mn |